The sclerosing hemangioma of lung (SHL) is an uncommon and uncertain histogenetic benign tumor first described by Liebow and Hubell in1956[@b1]. The histopathological morphology of SHL has been studied extensively by many investigators[@b2][@b3][@b4][@b5][@b6][@b7][@b8][@b9]. SHL is a well-circumscribed parenchymal tumor, which consists of two types of tumor cells: cuboidal tumor cells and polygonal tumor cells. In SHL, there are mainly four types of structure: solid, papillary, hemorrhagic and sclerotic patterns. However, the histogenesis of SHL has remained controversial. Previously, the cuboidal cells were considered to be entrapped alveolar pneumocytes and bronchiolar epithelium, and polygonal cells were considered to be tumor cells. Now, both cuboidal cells and polygonal cells are considered to be tumor cells present in the same tumor[@b10]. The p40 antibody (antibody recognizing ΔNp63 only)isanisoform of p63. The single expression of ΔNp63 is seen in stem-like cell populations and may contribute significantly to biological processes such as proliferation and differentiation of epithelia. The objective of this study is to explore the histogenesis of SHL by analyzing the clinical pathological data and p40 immunohistochemical results of 18 cases of SHL.

Results
=======

The clinical data
-----------------

Among the 18 cases of SHL, there were 16 women and 2 men, indicating a female/male ratio of 8:1. The patients ranged in age from 26 years to 58 years old, with a mean age of 44.6 years. The course of disease varied from 20 days to 2 years. All patients experienced cough, sputum production, chest pain, chest tightness, and chest discomfort. Ten tumors occurred in the right lower lobes, four in the left lower lobes, one in the right upper lobes, three in the left upper lobes ([Table 1](#t1){ref-type="table"}). The radiological appearance indicated a solitary mass or nodule in all cases.

Pathology observation
---------------------

Gross features - A solitary tumor was observed in the parenchyma in part of the lung tissue removed by surgery, with a well-circumscribed mass or nodule that was easy to separate from surrounding pulmonary tissues. The mass or nodule was round or oval,with a diameter of 1 cm to 4 cm (average diameter of 3 cm). The tumors\' cut surfaces presented as meaty, coloring from gray-tan to darkred. Histologic features - All 18 cases showed the typical histologic appearances of SHL described below: there were two types of tumor cells ([Figure 1](#f1){ref-type="fig"}): cuboidal tumor cells and polygonal tumor cells. Polygonal tumor cells showed uniform, medium-size polygonal or round nuclei with moderate amounts of eosinophilic or clear cytoplasm. Cuboidal tumor cells were characterized by a small and deeply stained nucleus. Neither necrosisn or mitotic activity was found in these two types of tumor cells in SHL. Tumor structure showed solid, papillary, hemorrhagic and sclerotic patterns. In the solid area, the aggregation of polygonal cells was observed. The cuboidal tumor cells formed glandular-like structures or clefts. In the papillary area, the papillary surface was lined with cuboidal tumor cells. The polygonal tumor cells were visible in the papillary axis. The sclerotic area was formed by hyaline collagen tissues and the proliferation of fibrous tissue. Hemorrhagic areas were filled with vascular-like channels or true vessels which were packed with varying amounts of erythrocytes. Typical polygonal tumor cells were always in the interstitium. Lymphocytes, hemosiderin, cholesterol fissures, xanthomacells and calcification could be observed in interstitium.

Immunohistochemistry
--------------------

Positive expression of p40 was observed in cuboidal tumor cells ([Figure 2](#f2){ref-type="fig"}) and basal cells of glandular structures of bronchi ([Figure 3](#f3){ref-type="fig"}) in all 18 cases of SHL (18/18, 100%), No positive expression of p40 could be found in polygonal tumor cells (0/18, 0%) and normal alveolar epithelium surrounding the tumor. In all 18 cases of SHL, TTF-1 ([Figure 4](#f4){ref-type="fig"}) and EMA were expressed in both polygonal tumor cells and cuboidal tumor cells(18/18, 100%). Cuboidal tumor cells showed cytoplasmic positivity for EMA and polygonal tumor cells displayed the main immuoreaction in membrane. CKpan was expressed in cuboidal tumor cells in some cases (14/18) but not in polygonal tumor cells in any case (0/18, 0%).Vimentin was diffusely expressed in polygonal tumor cells(18/18, 100%)and in cuboidal tumor cells in some cases(6/18). SPB positive expression was observed in cuboidal tumor cells (18/18, 100%), but not in polygonal tumor cells(0/18, 0%). Focal CgA and Syn positive expression in polygonal tumor cells was observed in only one case. CD34 was expressed only in the vascular endothelial cells. Positive expression of Ki-67 was scattered in a small number of tumor cells (less than 5% in all cases). SMA expression was negative in all tumor cells ([Table 2](#t2){ref-type="table"}, [Table 3](#t3){ref-type="table"}).

Discussion
==========

By studying SHL pathological manifestation and immunohistochemistry, it was demonstrated that there are two types of tumor cells in SHL: cuboidal tumor cells and polygonal tumor cells. Until now, the histogenesis of polygonal cells and cuboidal cells in SHL has remained unclear. Several theories on the tissue source of SHL have been proposed in the literature as follows: 1.Endothelialcell origin: in 1956, Liebow and Hubbell[@b1] firstly reported seven cases of SHL. They proposed that SHL was a primary proliferation of blood vessels accompanied by secondary epithelial proliferation. It was suggested that SHL originated from vascular endothelial cells, and that its morphology was similar to that of skin sclerosing hemangioma. However, the endothelial origin was not supported by subsequent studies; only tumor vascular endothelial cells were positively labeled, while endothelial cell markers of both polygonal tumor cells and cuboid tumor cells were unlabeled[@b5].Therefore, endothelial cells might simply be the squeezed alveolar epithelial cells. 2.Mesothelial cell origin, which was described by Katzensteinal, et al.[@b7] The authors used electron microscopy data to support their belief that SHL originated from mesothelial cells. However, no morphological manifestation of mesothelial cells was found in subsequent electron microscopy studies. In addition, neither polygonal tumor cells nor cuboidal tumor cells expressed mesothelial cell-specific markers, such as CR and CK5/6, by the immunohistochemistry method. Therefore, this theory can be discarded, based on morphological observation and immunohistochemistry data. 3.Neuroendocrine cells origin: Xu et al.[@b8] suggested that SHL originated from neuroendocrine cells. However later studies showed that in some cases a small amount of polygonal tumor cells expressed neuroendocrine markers. In our study, expression of CgA and Syn in polygonal tumor cells was observed in only one case, and no electron dense granules of typical neuroendocrine particle morphology were observed under the electronmicroscope. We have not found sufficient evidence to support SHLneuroendocrine origin, because the small amount of CgA and Synpositive cells might be the result of differentiation of tumor cells towards neuroendocrine cells. 4.Primitive alveolar epithelial cellorigin[@b3][@b4][@b5][@b6]:Through the immunohistochemical study of 100 SHL cases, Devouassoux et al.[@b3] found that TTF-1, SPB, EMA and CK positive expression rates in tumor cells were very high, and that TTF-1 and SPB were the characteristic antigens of alveolar epithelial cells. This strongly suggested that SHL originated from the primitive respiratory epithelium. Hill and Kennedy[@b5][@b9] proved that SHL tumor cells had the characteristics of alveolar cells by electron microscopy. Therefore, they believed that SHL might originate from immature alveolar epithelial cells, and could be differentiated to alveolar cells,Clara cells and neuroendocrine cells. The results of the present study proved that the cuboidal tumor cells expressed CKpan, SPB, TTF-1 and EMA, and polygonal cell tumor cells expressed TTF-1 and EMA, which supports the SHL primitive alveolar epithelial cell origin. The lack of reaction of Syn, CgA,CD34, and SMA supported the pulmonary epithelium origin, rather than neuroendocrine or vascular-endothelium. In addition, we found that p40 was exclusively expressed in cuboidal tumor cells,not in polygonal tumor cells and alveolar epithelial cells in tumor-surrounding normal lungtissue. p40 antibody(antibody recognizing ΔNp63 only)is a p63 isoform. The p63 gene encodes diverse mRNA isoforms,which are generated by the activity of two different promoters, one of which is internal to exon 3, which lead to the accumulation of TAp63 isoforms acting as TA agents, favoring cell cycle arrest with apoptosis and cell differentiation induction and ΔNp63-p40 isoforms,acting as negative dominant agents, which stimulate cell proliferation and block apoptosis with unrestrained tumor cell growth. In particular, recent data has indicated important roles in adult stem cell and cancer stem cell regulation[@b11]. p63 was consistently expressed in basal cells of normal epithelia, such as skin,urothelium, ectocervix and vagina, and basal cells of glandular structures of bronchi, and prostate. Importantly, these cells predominantly expressed the ΔNp63 isotype at about 100-fold to TAp63[@b12]. ΔNp63 was thought to function as a stem cell factor, responsible for maintaining cells in an uncommitted state with regenerative potential--a role that may be recapitulated in tumors derived from these cells[@b12][@b13]. Elevated expression of ΔNP63 isoforms has been found in several carcinomas, indicating an oncogenic role of ΔNP63 isoforms[@b14]. According to Nobre et al.[@b15], the single expression of ΔNp63 was seen in the stem-like cell populations and may contribute significantly to biological processes such as proliferation and differentiation of epithelia. William[@b16] found that ΔNp63 was an oncogene that cooperates with Ras to promote tumor-initiating stem-like proliferation in vivo. Celeste[@b17] found that ΔNp63 plays a fundamental role in early epidermal development and ΔNp63 was an anti-apoptotic Factor during epidermal development in Xenopus. All this suggests that the p40-positive cells may be undifferentiated pluripotent stem cells. Therefore, we hypothesized that p40-positive expressing cuboidal tumor cells might be the original alveolar epithelial cells in SHL, whereas polygonal tumor cells were differentiation manifestations of cuboidal tumor cell.

Methods
=======

The study was approved by the Institutional Ethics Committee of HuaianFirst People\'s hospital. All activities involving human subjects were done under full compliance with government policies and the Helsinki Declaration. Written informed consent was obtained from all study subjects. All SHL cases were diagnosed with surgical resection and histopathological examination in our hospital. Clinical data were reviewed from the patients\' charts. All specimens were fixed by 10%neutral formalin, embedded in paraffin and the slices were approximately 4 μm, Hematoxylin-eosin stained, and diagnosis of SHL was confirmed by two doctors with the result of light microscopy. Further immunohistochemical staining was performed on paraffin sections labeled by the EnVision method. Antigen retrieval was effected by pressure cooking in EDTA buffer, pH 8.0 for 2.5 minutes[@b2]. Primary antibodies were anti-p40 (5--17, CalBiochem/END Bioscrience, cat, NO, PC373), anti-Cytokeratinpan (CKpan, AE1/AE3, DaKo), anti-Epithelical Membrane Antigen (EMA,V9, DaKo), anti-Surfactant Protein B (SPB, AB3780, Chemicon International), anti-vimentin (Vim384, DaKo),anti-Thyroid Transcription Factor-1 (TTF-1, 8G7G3/1, DaKo,) anti-CD34(QBEnd/10, DaKo), anti-Ki67 Antigen (M1B5, DaKo), anti-Synaptophysin (Syn, SY38, DaKo, anti- Chromogranin A (CgA, DAK-A3, DaKo), and anti- Smooth Muscle Actin (SMA, 1A4, DaKo). The reaction was visualized by using DAB and then the sections were counter stained with hematoxylin. Cuboidal tumor cells and polygonal tumor cells were separately counted. For p40, TTF-1 and Ki-67staining, yellowish-brown granule in nuclei were considered as positive; for CKpan, EMA, vimentin, SPB, CgA, Syn CD34 and SMA staining, yellow or brown granules in a membranous or cytoplasmic pattern were considered as positive. For all antibodies, the percentage and positive intensity was calculated based on the actual number of positive cells; Immunoreactivity was rated semiquantitatively on a scale from negative (−) to positive (+). The number of counted cells \< 10% was considered negative (−); the number of counted cells \> 10%was positive (+)[@b2][@b3]. Staining intensity: "+" indicated weak,++ moderate of strong. The positive control was the positive reaction for each antibody; and negative control was the reaction in which primary antibody was replaced with PBS.
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![P40 positive expression in cuboidal tumor cells and no positive expression in polygonal tumor cells in SHL.\
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![P40 positive expression in basal cells of glandular structures of bronchi in SHL.\
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![TTF-1 positive expression in both the cuboidal tumor cells and polygonal tumor cells in SHL.\
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###### Patient in SHL informations

  N     Sex   Age   Course of disease(m)   Size of tumor (cm)   location of tumor
  ---- ----- ----- ---------------------- -------------------- -------------------
  1      F    26          20 days                  1            right lower lobes
  2      F    58             24                    4            right lower lobes
  3      F    42             4                     2            right lower lobes
  4      F    37             3                    2.5           right lower lobes
  5      F    41             6                    3.8           right lower lobes
  6      F    40             1                    3.2           right lower lobes
  7      F    50             2                    3.6           right lower lobes
  8      F    33             1                    2.8           right lower lobes
  9      F    38             2                    2.2           right lower lobes
  10     F    44             3                    3.3           left lower lobes
  11     F    37             1                    1.9           left lower lobes
  12     F    45             1                    2.7           left lower lobes
  13     F    38             3                    2.6           left lower lobes
  14     F    49             1                    3.1           right upper lobes
  15     F    48             1                    2.6           left upper lobes
  16     F    44             1                    3.8           left upper lobes
  17     M    50             6                    3.6           left upper lobes
  18     M    51             10                   3.6           right lower lobes

M: Male, F: Female,m: month, cm: centimetre.

###### Expression of immunophenotype of P40,TTF-1,EMA,CKpan,Vimetin,SPB,CD34, SMA in 18 cases of SHL

  Type of tumor cells               Positive counting cells                                                                                                                    
  ----------------------- ---------------------------------- ----------- --------- ----------- ------------- --------- ---------- --------- ---- ---- ---- ---- ---- ---- ---- ----
                                           P40                    TTF-1       EMA       CKpan       Vimetin       SPB       CD34       SMA                                     
                                          −                      \+          −         \+            −          \+         −         \+      −    \+   −    \+   −    \+   −    \+
  Cuboidal tumor cells                    0                      18          0         18            0          18         4         14      12   6    0    18   18   0    18   0
  Polygonal tumor cells                   18                      0          0         18            0          18         18         0      0    18   18   0    18   0    18   0

Positive counting cells: +,the number of positive cells \> 10%, −, the number of positive cells \< 10%.

###### Expression of immunostaining intensity of P40,TTF-1,EMA, CKpan,Vimentin, SPB in 18 cases of SHL

  Type of tumor cells               Immunostaining staining intensity                                                                                     
  ----------------------- -------------------------------------------- ----------- --------- ----------- ------------- --------- ---- ---- ---- ---- ---- ----
                                                P40                         TTF-1       EMA       CKpan       Vimetin       SPB                           
                                               \+                          ++         \+         ++           \+          ++      \+   ++   \+   ++   \+   ++
  Cuboidal tumor cells                         0                           18          0         18           18           0      14   0    6    0    18   0
  Polygonal tumor cells                        0                            0          0         18           18           0      0    0    0    18   0    0

Immunostaining staining intensity:+ weak,++ moderate or strong.
